Neurosterix Pharma Sàrl

Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators — molecules that increase or decrease the activity of target receptors by binding outside of the “active site” where endogenous ligands and traditional drugs operate. Through this platform, Neurosterix’s novel drug candidates have the potential to provide me

Date, time and room information

May 6, 15:00 - 15:15, room Singapore

Category
Emerging biotech company
Title of the presentation
Neurosterix - Corporate Presentation
Speaker information
Name Position Institution
Tim Dyer CEO